Cocaine, Marijuana, Designer Drugs Chemistry, Pharmacology, and Behavior

Published in 1989: A comprehensive review of the chemical, clinical, pharmaco-logical, medical and social aspects of the chemicals that are widely abused is presented in this highly informative publication. The contributing authors represent expertise in clinical medicine, pharmacy, chemistry, pharmacology, social work and psychiatry. The scientific discussion, phar-macokinetic, pharmacological, and analytical, is well tied to the behavioral aspects of substances of abuse, making this a unique publication.

1. Introduction Kinfe. K. Redda and Charles A. Walker 2. The national Perspective of Drug Abuse Elaine M. Johnson 3. Behavorial Pharmacology of Drug Abuse James P. Cleary and Kenneth D. McIntire 4. Getting Involved in Drug Abuse Education and Prevention Carol Bolach 5. Pharmacology of Cocaine Abuse Roger M. Brown 6. Cocaine Kinetics in Humans John J. Ambre 7. Cocaine Pharmacology and Toxicology Randall L. Commissaris 8. Cocaine Use in Man: Subjective Effects, Physiologic Responses, and Toxicity Karen M. Kumor, Michael A. Sherrer, and Nicola G. Cascella 9. Treatment of Cocaine Abuse: Medical and Psychiatric Consequences Maria-Elena Rodriguez 10. Marijuana Pharmacokinetics and Pharmacodynamics C. Nora Chiang and Gene Barnett 11. Marijuana Abuse: Its Pharmacology and Effects on Testicular Function Syed Husain 12. Marijuana Analysis and Detection of Use Through Urinalysis Mahmoud A. Elsohly and Hala N. Elsohly 13. Designer Drugs: An Overview Gene Barnett and Rao S. Rapaka 14. Substituted Amphetamine Controlled Substance Analogues David E. Nichols 15. Pharmacology and Toxicology of MPTP: A Neurotic By-Product of Illicit Designer Drug Chemistry Anthony Trevor, Neal Castagnoli, Jr., and Thomas P. Singer 16. Methyl-Phenyl-Tetrahydropyridine Neurotoxicity: From Clandestine Drug Synthesis to a Model for Parkinson’s Disease Jordi Cami 17. Uses and Abuses of Anabolic Steroids by Athletes Sayed M. H. Al-Habet, Kinfe K. Redda, and Henry J. Lee

Kinfe "Ken" Redda, Ph.D., is at present an Associate Professor of Medicinal Chemistry at the College of Pharmacy and Pharmaceutical Sciences, Florida A & M University (FAMU), Tallahassee. Charles A. Walker, Ph.D., is presently Chancellor of the University of Arkansas at Pine Bluff. Gene Barnett, Ph.D., is presently serving as an associate of the Director of the Food and Drug Administration’s (FDA) Division of Cardio-Renal Drug Products in the area of drug pharmacokinetics.